23 October 2026RSS feed
PR●Press Release IndiaTHE BUSINESS ANNOUNCEMENT WIRE
Business announcements.
Direct from the source.
NEWSROOM / INDIA

The latest on the wire

Browse announcements from the Press Release India archive.

UPDATED THROUGHOUT THE DAY
Business wire18453

Boehringer Ingelheim Enters Clinical Collaboration with Amgen to Study BI 1701963, a SOS1::pan-KRAS Inhibitor, in Combination with LUMAKRAS™ (sotorasib), a KRASG12C Inhibitor

Combination of leading SOS1::pan-KRAS inhibitor with the first US FDA approved KRASG12Cinhibitor has the potential to demonstrate additional therapeutic benefit for people living with KRAS G12C mutated cancers The new clinical partnership adds to Boehringer In